…assurance practices, and compounding-specific requirements. Compounding pharmacies must be in alignment with all applicable USP sections and FDA 503A requirements: A pharmacy performing non-sterile compounding must comply with the current…
More ›The Iowa state board of pharmacy and NABP collaborate to publish a newsletter with a focus on promoting compliance of pharmacy and drug law. View the June 2021 newsletter.
More ›The Washington board of pharmacy and NABP collaborate to publish a newsletter with a focus on promoting compliance of pharmacy and drug law. View the November 2025 newsletter.
More ›Caroline Juran, BSPharm, DPh (Hon), presented the Report of the Executive Committee during the 119th Annual Meeting.
More ›The Utah board of pharmacy and NABP collaborate to publish a newsletter with a focus on promoting compliance of pharmacy and drug law. View the August 2025 newsletter.
More ›The Utah board of pharmacy and NABP collaborate to publish a newsletter with a focus on promoting compliance of pharmacy and drug law. View the February 2024 newsletter.
More ›The work group reviewed and discussed the various provisions that had been waived by the boards of pharmacy during the past 16 months due to the COVID-19 public health emergency….
More ›The Arizona board of pharmacy and NABP collaborate to publish a newsletter with a focus on promoting compliance of pharmacy and drug law. View the October 2023 newsletter.
More ›The Wyoming state board of pharmacy and NABP collaborate to publish a newsletter with a focus on promoting compliance of pharmacy and drug law. View the June 2021 newsletter.
More ›The Kentucky state board of pharmacy and NABP collaborate to publish a newsletter with a focus on promoting compliance of pharmacy and drug law. View the March 2021 newsletter.
More ›